Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
After finishing at $1.31 in the prior trading day, Silexion Therapeutics Corp (NASDAQ: SLXN) closed at $1.28, down -2.29%. In other words, the price has decreased by -$2.29 from its previous closing price. On the day, 8.51 million shares were traded. SLXN stock price reached its highest trading level at $1.35 during the session, while it also had its lowest trading level at $1.19.
Ratios:
Our goal is to gain a better understanding of SLXN by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.85 and its Current Ratio is at 0.85.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SLXN now has a Market Capitalization of 10770713 and an Enterprise Value of -153950.
Stock Price History:
The Beta on a monthly basis for SLXN is -0.06, which has changed by -0.88478845 over the last 52 weeks, in comparison to a change of 0.09589827 over the same period for the S&P500. Over the past 52 weeks, SLXN has reached a high of $122.02, while it has fallen to a 52-week low of $0.57. The 50-Day Moving Average of the stock is -5.33%, while the 200-Day Moving Average is calculated to be -95.87%.
Shares Statistics:
The stock has traded on average 14.23M shares per day over the past 3-months and 10123130 shares per day over the last 10 days, according to various share statistics. A total of 8.41M shares are outstanding, with a floating share count of 7.65M. Insiders hold about 9.05% of the company’s shares, while institutions hold 7.03% stake in the company. Shares short for SLXN as of 1740700800 were 976476 with a Short Ratio of 0.07, compared to 1738281600 on 1597588. Therefore, it implies a Short% of Shares Outstanding of 976476 and a Short% of Float of 12.24.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
